Patents expiring in 2031

US 7888069

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

The United States of America as represented by the Secretary of Argriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888068

Cloning of honey bee allergen C

PLS-Design GmbH · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887836

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892730

Compositions and methods for cancer

Sagres Discovery, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893022

Anti-angiogenic methods and compositions

Sangamo Biosciences, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892738

Pot1 alternative splicing variants

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892755

Screening method

Takeda Pharmaceutical Company Limited · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892786

Methods for expression and purification of immunotoxins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893206

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

Xenon Pharmaceuticals Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893256

Azabicycloalkane compounds

Theravance, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893027

Treatment of ocular wounds and ulcers

The Board of Regents of the University of Oklahoma · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893033

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893087

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893224

Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7893299

Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators

The Regents of the University of California · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892777

Methods for measuring whether a treatment affects RPTP-κ activity

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892569

Methods of altering an immune response induced by CpG oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892539

Modulation of an innate immune response by altering TRIAL-R signaling

The Regents of the University of California · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892567

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892554

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7892008

Electrical connector having metallic lock

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897617

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897152

Viral chemokine-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7896914

Coated implantable medical device

Cook Regentec LLC · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897340

Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

The Board of Regents of the University of Texas System · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897763

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897575

Treatment and prevention of vascular dementia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897775

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897355

Gene expressed in prostate cancer and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897791

Purifications of pomegranate ellagitannins and their uses thereof

The Regents of the University of California · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897607

Cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7897588

Agents and methods for enhancing bone formation

The Regents of the University of California · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902220

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902239

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902166

Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same

The Board of Regents of the University of Oklahoma · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7901921

Viral purification methods

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902228

Schweinfurthin analogues

The United States of America, National Institute of Health · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902221

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902235

Compounds for nonsense suppression, and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7901453

Coated implantable medical device

Cook Regentec LLC · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902148

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902167

Compounds and methods for down-regulating Wrap53 protein by RNA interference

APREA AB · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902348

Janus family kinases and identification of immune modulators

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902441

Chromosome 3p21.3 genes are tumor suppressors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902241

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7902168

Compositions and methods for inhibiting expression of Nav1.8 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906513

Hydrazide-containing hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906491

Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)

Univisitair Medisch Centrum Utrecht · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)